CurrentCardio
Get Weekly

Topic · page 6 of 28

Coronary disease & ACS

Acute and chronic coronary syndromes, MI, INOCA/ANOCA, revascularisation strategy, antithrombotic therapy after ACS/PCI, chest-pain diagnostics

Briefs 201–240 of 1,104 placed here, newest publication first

Briefs in Coronary disease & ACS

Newest publication first

  1. JACC Cardiovasc Interv

    Abbreviated DAPT Regimens Across the Entire Spectrum of Bleeding Risk According to the PRECISE-HBR Score

    Meta-analysis

  2. JACC Adv

    Increased Platelet FcɣRIIa Identifies Patients at Greater Risk of Multiple Cardiovascular Events After Myocardial Infarction

    Cohort study

  3. Circ Cardiovasc Interv

    Abbreviated Dual Antiplatelet Therapy in Patients With High Bleeding Risk Undergoing PCI of Bifurcation Lesions: A Prespecified Substudy of the MASTER DAPT Trial

    Secondary analysis

  4. Am Heart J

    Antegrade dissection and re-entry vs retrograde strategy in chronic total occlusion percutaneous coronary intervention: Rationale and design of the ADRENALINE randomized study

    Trial design

  5. Eur J Prev Cardiol

    Rheumatoid arthritis and risk of myocardial infarction: A nationwide cohort study

    Cohort study

  6. Eur J Prev Cardiol

    Sex-specific effects of depression on the incidence and risk factors for coronary heart disease: insights from multi-omics approaches

    Cohort study

  7. Circ Cardiovasc Interv

    Optical Coherence Tomography Characterization of Coronary Lithotripsy Following Atherectomy for Treatment of Severely Calcified Lesions

    Secondary analysis

  8. Circ Popul Health Outcomes

    Neighborhood Social Determinants of Health and Referral to Cardiac Rehabilitation: An Analysis of the Get With The Guidelines–Coronary Artery Disease Registry

    Cross-sectional study

  9. JACC Cardiovasc Imaging

    Association of Hemodynamic Disease Severity and Distribution With Risk of Future Acute Coronary Syndrome

    Case-control study

  10. ESC Heart Fail

    Clonal haematopoiesis and outcomes after acute coronary syndrome: a systematic review and meta-analysis

    Meta-analysis

  11. Am Heart J

    International study of coronary microvascular angina (iCorMicA): A registry-based diagnostic study and nested randomized trial

    Trial design

  12. Heart Rhythm

    Management of engraftment arrhythmias associated with human-induced pluripotent stem cell-derived cardiomyocytes transplantation

    Research article

  13. Am Heart J

    Stratified medicine with eplerenone for myocardial infarction or injury and no obstructive coronary arteries: A registry-based basket trial

    Trial design

  14. Circ Popul Health Outcomes

    Variability in Cardiac Stress Test Interpretation: Agreement Between Enrollment Sites and Core Laboratories in the Global ISCHEMIA Trial

    Randomised controlled trial

  15. J Am Coll Cardiol

    Ultra-Thin Sirolimus-Eluting Versus Everolimus-Eluting Stents in Diabetic Multivessel Coronary Artery Disease Patients: The TUXEDO-2 Trial

    Randomised controlled trial

  16. JAMA Cardiol

    Efficacy and Safety of Prasugrel, Ticagrelor, or Clopidogrel After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis

    Meta-analysis

  17. JAMA Cardiol

    Multiple Endotypes and Angina Burden in Patients With Nonobstructive Coronary Arteries

    Cross-sectional study

  18. JAMA Cardiol

    Pathological Analysis of Lipoprotein(a) Risk Variants and Culprit Coronary Thrombotic Lesions

    Cross-sectional study

  19. J Am Coll Cardiol

    Antiplatelet Therapy in the Management of Atherosclerotic Cardiovascular Disease: 2026 ACC Scientific Statement: A Report of the American College of Cardiology

    Guideline or statement

  20. Heart

    Optimal timing of aspirin discontinuation after acute coronary syndrome treated with percutaneous coronary intervention: a systematic review and meta-analysis

    Meta-analysis

  21. Heart

    Long-term cardiovascular outcomes in patients hospitalised with acute coronary syndrome subtypes in Western Australia, 2002–2019

    Cohort study

  22. Eur Heart J Acute Cardiovasc Care

    One-year and 5-year transition risks between major bleeding, reinfarction, and death following acute myocardial infarction in England and Wales: a population-based cohort study

    Cohort study

  23. Circ Cardiovasc Interv

    Nicorandil to Prevent Contrast-Associated Kidney Injury in High-Risk PCI

    Randomised controlled trial

  24. Eur Heart J Cardiovasc Imaging

    Long-term prognostic value of stress cardiovascular magnetic resonance in patients with hypertension without known coronary artery disease

    Cohort study

  25. Am Heart J

    Prognostic impact of combined inflammatory markers in patients undergoing percutaneous coronary intervention

    Research article

  26. Am Heart J

    Lessons learned from the feasibility phase of the REvascularization CHoices Among Under-Represented Groups Evaluation (RECHARGE) trial program

    Randomised controlled trial

  27. Eur J Prev Cardiol

    Prognostic impact of sarcopenia following myocardial infarction: a systematic review and meta-analysis of mortality and recurrent MI

    Meta-analysis

  28. Heart

    Prognosis of patients with ST-elevation myocardial infarction presenting to the emergency department without chest pain: a retrospective nationwide cohort study

    Cohort study

  29. Heart

    Presence and type of bystanders on delay time in acute myocardial infarction: a transcultural cross-sectional clinical study with 907 patients in Shanghai and Munich

    Cross-sectional study

  30. JACC Adv

    Left Ventricular Ejection Fraction Trajectory and Long-Term Outcomes Following Percutaneous Coronary Intervention for Myocardial Infarction

    Cohort study

  31. Am Heart J

    The effect of zalunfiban on high sensitivity cardiac troponin and the association with clinical outcomes in patients with STEMI

    Secondary analysis

  32. JACC Cardiovasc Imaging

    Integrated Coronary CT Angiography Assessment of Plaque Vulnerability and Clinical Outcomes: The Morphology-Inflammation-Burden (MIB) Score

    Cohort study

  33. Circulation

    Sirolimus-Eluting Balloon With Provisional Stenting Versus Systematic Drug-Eluting Stent Implantation to Treat De Novo Coronary Lesions: A Randomized, Open-Label, Noninferiority Trial

    Randomised controlled trial

  34. Eur Heart J Acute Cardiovasc Care

    Safety and efficacy of ivabradine in the treatment of patients with acute myocardial infarction: a real-world propensity score matching study

    Research article

  35. EuroIntervention

    Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks. A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular Pharmacology A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular Pharmacology

    Guideline or statement

  36. Circ Popul Health Outcomes

    Patient Perspectives in Cardiovascular Research: A Qualitative Study of Barriers, Trust, and Strategies for Inclusive Clinical Trials

    Research article

  37. JACC Adv

    Predicting Intramyocardial Hemorrhage Before Reperfusion in STEMI Patients With Intrinsically Explainable Artificial Intelligence

    Diagnostic or prognostic study

  38. JACC Adv

    Impact of IVUS Guidance on Clinical and Procedural Outcomes in Intracoronary Brachytherapy

    Cohort study

  39. J Am Coll Cardiol

    Angiographic Quantitative Flow Ratio-Guided Coronary Intervention: 5-Year Follow-Up From the FAVOR III China Randomized Trial

    Secondary analysis

  40. Circulation

    Heart Rate and Cardiovascular Outcomes in Post–Myocardial Infarction Patients Treated by β-Blockers: A Secondary Analysis of the ABYSS Trial

    Secondary analysis

All 1,104 Briefs in ExploreShowing Briefs 201–240 of 1,104, newest first